Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

Bruce M. Psaty, Noel S. Weiss, Curt D. Furberg, Thomas D. Koepsell, David S. Siscovick, Frits R. Rosendaal, Nicholas L. Smith, Susan R. Heckbert, Robert C. Kaplan, Danyu Lin, Thomas R. Fleming, Edward H. Wagner

Research output: Contribution to journalComment/debate

162 Scopus citations
Original languageEnglish (US)
Pages (from-to)786-790
Number of pages5
JournalJournal of the American Medical Association
Volume282
Issue number8
DOIs
StatePublished - Aug 25 1999
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Psaty, B. M., Weiss, N. S., Furberg, C. D., Koepsell, T. D., Siscovick, D. S., Rosendaal, F. R., Smith, N. L., Heckbert, S. R., Kaplan, R. C., Lin, D., Fleming, T. R., & Wagner, E. H. (1999). Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. Journal of the American Medical Association, 282(8), 786-790. https://doi.org/10.1001/jama.282.8.786